Solis Mammography's Successful Exit Yields $3.5 Million Return

RWB Group AG has successfully exited its investment in Solis Mammography, a U.S.-based company specializing in breast cancer detection. Solis Mammography aimed to provide a professional and comfortable environment for women undergoing screening, employing state-of-the-art technology. The private equity firm Audax initially invested in Solis Mammography in 2015, facilitating significant expansions including doubling the number of screening centers and entering various strategic partnerships. After selling a major portion of its shares in 2018, Audax recently sold its remaining stake, cumulatively returning nearly $3.5 million to RWB's International II, III, and V funds, and the 'Cost Average' fund. These developments underscore the successful growth strategy and value creation imparted by the partnership with Audax.